Global Biotechnology, Ibisworld
NEW YORK, Nov. 20, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Biotechnology, Ibisworld
http://www.reportlinker.com/p01045182/Global-Biotechnology-Ibisworld.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biotechnology
Global Biotechnology
In the past five years, the global recession tempered demand for nonessential health products and reduced funding for biotechnology research and development from private investors. Despite these factors, industry firms thrived on the back of technological advances that facilitated new discoveries and stimulated greater demand from firms in the pharmaceuticals and agricultural sectors. Industry growth is forecast to continue skyrocketing in the next five-year period as investment in biotechnology from around the world increases, particularly from emerging economies.
Firms in this industry primarily engage in the application of living organisms or molecular and cellular techniques to develop products that are used in agriculture, food, industrial and medicine production. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. TABLE OF CONTENTS ABOUT THIS INDUSTRY Industry Definition Main Activities Similar Industries Additional Resources INDUSTRY PERFORMANCEExecutive SummaryKey External DriversCurrent PerformanceIndustry OutlookIndustry Life Cycle PRODUCTS & MARKETS Supply Chain Products & Services Demand Determinants Major Markets International Trade Business Locations COMPETITIVE LANDSCAPEMarket Share ConcentrationKey Success FactorsCost Structure BenchmarksBasis of CompetitionBarriers to EntryIndustry Globalization MAJOR COMPANIES OPERATING CONDITIONSCapital IntensityTechnology & SystemsRevenue VolatilityRegulation & PolicyIndustry Assistance KEY STATISTICS Industry Data Annual Change Key Ratios JARGON MAJOR COMPANIES Amgen Inc. Merck KGaA Roche Holding AG To order this report: Biotechnology Industry: Global Biotechnology, Ibisworld Nicolas BombourgReportlinkerEmail: nicolasbombourg@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626 SOURCE Reportlinker
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
